ProCE Banner Activity

Medical Minute: Influence of Anxiety and Depression on MS and Associated Symptoms

Slideset Download
Review the clinical implications of anxiety and depression for patients with MS and guideline-based recommendations for proper diagnosis and treatment.

Released: August 26, 2021

Expiration: August 25, 2022

No longer available for credit.

Share

Faculty

Patricia K. Coyle

Patricia K. Coyle, MD, FAAN, FANA

Professor and Vice Chair (Clinical Affairs)
Director, MS Comprehensive Care Center
Department of Neurology
Stony Brook University Hospital
Stony Brook, New York

Patricia Melville

Patricia Melville, ANP-BC, MSCN

Clinical Instructor
Neurology/MS Comprehensive Care Center
Stony Brook University Medical Center
Stony Brook, New York

Provided by

Provided by Consortium of Multiple Sclerosis Centers (CMSC), in collaboration with Clinical Care Options
ProCE Banner

Supporters

Supported by educational grants from

Biogen

Bristol Myers Squibb

Faculty Disclosure

Primary Author

Patricia K. Coyle, MD, FAAN, FANA

Professor and Vice Chair (Clinical Affairs)
Director, MS Comprehensive Care Center
Department of Neurology
Stony Brook University Hospital
Stony Brook, New York

Patricia K. Coyle, MD, FAAN, FANA, has disclosed that she has received consulting fees from Accordant, Alexion, Bayer, Biogen, Bristol-Myers Squibb, Celgene, EMD Serono, Genentech/Roche, GlaxoSmithKline, Janssen, Mylan, Novartis, Sanofi Genzyme, TG Therapeutics, and Viela Bio; funds for research support from Alkermes, Corrona, Genentech/Roche, MedDay, and NINDS; and fees for non-CME/CE services from Biogen and Janssen.

Patricia Melville, ANP-BC, MSCN

Clinical Instructor
Neurology/MS Comprehensive Care Center
Stony Brook University Medical Center
Stony Brook, New York

Patricia Melville, ANP-BC, MSCN, has disclosed that she has received consulting fees from Alexion, Biogen, Celgene/Bristol-Myers Squibb, Genentech, and Sanofi Genzyme and fees for non-CME/CE services from Alexion, Biogen, Celgene/Bristol-Myers Squibb, Genentech, Novartis, and Sanofi Genzyme.